Journal
DRUG DISCOVERY TODAY
Volume 14, Issue 9-10, Pages 509-515Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2009.02.011
Keywords
-
Categories
Ask authors/readers for more resources
The histamine H3 receptor plays a regulatory role in the pre-synaptic release of histamine and other neurotransmitters, making it an attractive target for CNS indications including cognitive disorders, narcolepsy, ADHD and pain. As more and more H3 antagonists/H3 inverse agonists progress through the clinic, knowledge is gained to define the profile of the 'ideal' compound in terms of specificity, pharmacokinetic parameters and both duration and magnitude of receptor occupancy. Whether a single compound profile for the treatment of different disorders can be defined remains to be seen.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available